| abstract |
The present invention belongs to the technical field of medicine. In particular, the present invention relates to uses of benzenesulfonamido benzamide compounds for inhibiting liver fibrosis, or preventing and/or treating liver injury, or improving liver function, or preventing and/or treating liver diseases associated with liver fibrosis, a use thereof for regulating (i.e. reducing) the content of collagen in liver tissue (such as type I collagen), a use thereof for regulating (i.e. inhibiting) the activity of a COL1A1 promoter in cells, and a use thereof for regulating (i.e. inhibiting) the expression level of genes associated with liver fibrosis in cells. |